The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis

Journal of Periodontology

Volumn 75, Issue 1, 2004, Pages 106-115

  Emingil, Gülnur ^a   Atilla, Gül ^a   Sorsa, Timo ^b   Luoto, Hanne ^c   Kirilmaz, Levent ^a   Baylas, Haluk ^a  

^a EGE UNIVERSITY   (Turkey)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Medix Biochemica Oy Ab ^*  (Finland)

Author keywords

Adjunctive therapy; Clinical trials, controlled; Clinical trials, randomized; Collagenase; Double blind method; Doxycycline therapeutic use; Gingival crevicular fluid analysis; Periodontitis therapy; Planing; Scaling; Tooth root

Indexed keywords

DOXYCYCLINE; NEUTROPHIL COLLAGENASE; PLACEBO;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; FEMALE; FOLLOW UP; GINGIVITIS; HUMAN; LOW DRUG DOSE; MALE; PERIODONTITIS; PERIODONTIUM; PREVENTIVE DENTISTRY; PROTEIN LOCALIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TOOTH PLAQUE;

ADULT; ANTI-BACTERIAL AGENTS; DENTAL SCALING; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTITIS; STATISTICS, NONPARAMETRIC;

EID: 1542360543     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.1.106     Document Type: Article

References (57)

1. Potempa J, Banbula A, Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 2000;24:153-192.
2. Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K, Kotiranta A, Sorsa T. Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J Clin Periodontol 1997; 24:237-248.
3. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Dis 1996;2:70-76.
4. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64: 474-484.
5. Reynolds JJ, Meikle MC. The functional balance of metalloproteinases and inhibitors in tissue degradation: Relevance to oral pathologies. J R Coll Surg Edinb 1997;42:154-160.
6. Sodek J, Overall CM. Matrix metalloproteinases in periodontal tissue remodelling. Matrix Suppl 1992;1:352-362.
7. Kinane DF. Metalloproteinases in the pathogenesis of periodontal diseases. Curr Opin Dent 1992;2:25-32.
8. Abe M, Kawamoto K, Okamoto H, Horiuchi N. Induction of collagenase-2 (matrix metalloproteinase-8) gene expression by interleukin-1β in human gingival fibroblasts. J Periodont Res 2001;36:153-159.
9. Wahlgren J, Maisi P, Sorsa T, et al. Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. J Pathol 2001; 194:217-224.
10. Sorsa T, Ding Y, Salo T, et al. Effects of tetracyclines on neutrophil, gingival and salivary collagenases. Ann N Y Acad Sci 1994;732:112-131.
11. Sorsa T, Uitto V-J, Suomalainen K, Vauhkinen M, Lindy S. Comparison of interstitial collagenases from human gingival, sulcular fluid, and polymorphonuclear leukocytes. J Periodont Res 1988;23:386-393.
12. Weiss SJ. Tissue destruction by human neutrophils. N Engl J Med 1989;320:365-379.
13. Page RC. Periodontal therapy: Prospects for the future. J Periodontol 1993;64:744-753.
14. Loesche WJ. The antimicrobial treatment of periodontal disease: Changing the treatment paradigm. Crit Rev Oral Biol Med 1999;10:245-275.
15. Listgarten MA. Nature of periodontal diseases: Pathogenic mechanisms. J Periodont Res 1987;22:172-178.
16. Kornman KS. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 1999;28:520-526.
17. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998;12:12-26.
18. Golub LM, Ramamurthy NS, McNamara TF. Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991;2:297-322.
19. Golub LM, Suomalainen K, Sorsa T. Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 1992;2:80-90.
20. Ingman T, Sorsa T, Suomalainen K, et al. Tetracycline inhibition and the cellular source of collagenase in gingical crevicular fluid in different periodontal diseases. A review article. J Periodontol 1993;64:82-88.
21. Pirilä E, Ramamurthy N, Maisi P, et al. Wound healing in ovariectomized rats: Effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases-8, -13 and type I collagen expression. Curr Med Chem 2001;8:281-294.
22. Golub LM, Wolff M, Lee HM, et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodont Res 1985;20:12-23.
23. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987;66:1310-1314.
24. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res 1990;25:321-330.
25. Golub LM, Wolff M, Roberts S, Lee HM, Leung M, Payonk GS. Treating periodontal diseases by blocking tissue-destructive enzymes. J Am Dent Assoc 1994;125:163-171.
26. Golub LM, Evans RT, McNamara TF, Lee HM, Ramamurthy NS. A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats. Ann N Y Acad Sci 1994;732:96-111.
27. Caton JG. Evaluation of Periostat for patient management. Compend Contin Educ Dent 1999;20:451-463.
28. Crout RJ, Lee HM, Schroeder K, et al. The "cyclic" regimen of low-dose doxycycline for adult periodontitis: A preliminary study. J Periodontol 1996;67: 506-514.
29. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319.
30. Ciancio S, Ashley R. Safety and efficacy of subantimicrobial dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res 1998;12:27-31.
31. Caton JG, Ciancio SG, Blieden TM, et al. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000;71:521-532.
32. Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treatment with subantimicrobial doses of doxcycline: Effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001; 28:146-156.
33. Caton JG, Ciancio SG, Blieden TM, et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: Post-treatment effects. J Clin Periodontol 2001;28:782-789.
34. Novak MJ, Johns LP, Miller RC, Bradshaw MH. Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. J Periodontol 2002;73:762-769.
35. Thomas JG, Metheny RJ, Karakiozis JM, Wetzel JM, Crout RJ. Long-term subantimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: Effects on subgingival bacterial population dynamics. Adv Dent Res 1998;12:32-39.
36. Walker C, Thomas J, Nango S, Lennon J, Wetzel J, Powala C. Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis. J Periodontol 2000;71:1465-1471.
37. Thomas J, Walker C, Bradshaw M. Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 2000;71:1472-1483.
38. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
39. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
40. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of Vitamin C. J Periodontol 1970;41:41-43.
41. Lamster IB, Hartley LJ, Oshrain RL. Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival crevicular fluid collected with filter-paper strips. Arch Oral Biol 1985;30:235-242.
42. Cimasoni G. Method of collection. Crevicular Fluid Updated. Basel, Switzerland: S. Karger; 1983:29-36.
43. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline. J Biol Chem 1997; 272:31504-31509.
44. Greenstein G. Periodontal response to mechanical non-surgical therapy: A review. J Periodontol 1992;63:118-130.
45. Socransky SS, Haffajee AD. Effect of therapy on periodontal infections. J Periodontol 1993;64:754-759.
46. American Academy of Periodontology. Parameter on periodontal maintenance. J Periodontol 2000;71:849-850.
47. Greenstein G, Lamster IB. Efficacy of subantimicrobial dosing with doxycycline. Point/counterpoint. J Am Dent Assoc 2001;132:457-465.
48. Killoy WJ. The use of locally-delivered chlorhexidine in the treatment of periodontitis. Clinical results. J Clin Periodontol 1998;25:953-958.
49. Chen HY, Cox SW, Eley BM, Mantyla R, Ronka H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 2000;27:366-369.
50. Mäntylä P, Kinane D, Luoto H, Tikanoja S, Sorsa T. MMP (matrix metalloproteinase)-8 in monitoring periodontal health and disease from gingival crevicular fluid (GCF) [abstract]. J Clin Periodontol 2000;97:317.
51. Demirel K, Baer PN, McNamara TF. Topical application of doxycycline on periodontally involved root surfaces in vitro: Comparative analysis of substantivity on cementum and dentin. J Periodontol 1991;62:312-316.
52. Michalowicz BS, Pihlstrom BL, Drisko CL, et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Maintenance response. J Periodontol 1995;66:708-715.
53. Suomalainen K, Sorsa T, Golub LM, et al. Specificity of the anticollagenase action of tetracyclines: Relevance to their anti-inflammatory potential. Antimicrob Agents Chemother 1992;36:227-229.
54. Golub LM, Sorsa T, Lee H-M, et al. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995; 22:100-109.
55. Sorsa T, Golub LM, Lee H-M, et al. The anti-collagenolytic effect of low-dose doxycycline (LDD) regimen in adult human periodontitis from gingival crevicular fluid (GCF) can be monitored by the immunological test for neutrophil collagenase (MMP-8). J Dent Res 1998;77(Spec. Issue): 647(Abstr. 123).
56. Sorsa T, Mäntylä P, Rönka H, et al. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci 1999;878:130-140.
57. Mäntylä P, Stenman M, Kinane DF, et al. Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J Periodont Res 2003;38:436-439.